C12N 2760/18834
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2760/18834 (Use of virus or viral component as vaccine) appears on 16 US grants and 13 published applications in this corpus.
Search patents in C12N- Granted patents
- 16
- Published applications
- 13
- Assignees
- 20
- Inventors
- 52
- Latest grant
- 9 Nov 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 2 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 1 |
| 2010 | 1 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 1 | 3 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Anticancer agent comprising HVJ-E and immune checkpoint protein inhibitor9 Nov 2021US 11,166,995 B2Genomidea Inc.
- Anti-Mycobacterium tuberculosis vaccine using sendai virus as vector10 Nov 2020US 10,828,359 B2ID Pharma Co., Ltd.
- Modified Sendai virus vaccine and imaging vector25 Jun 2019US 10,329,584 B2St. Jude Children?S Research Hospital
- Modified Sendai virus vaccine and imaging vector2 May 2017US 9,637,758 B2St. Jude Children?S Research Hospital
- Method for cancer immunotherapy and pharmaceutical compositions based on oncolytic non-pathogenic Sendai virus27 Dec 2016US 9,526,779 B2
- Anticancer agent comprising hvj-e and immune checkpoint protein inhibitor12 Sep 2019US 2019/0275091 A1Genomidea Inc.
- Anti-mycobacterium tuberculosis vaccine using sendai virus as vector29 Mar 2018US 2018/0085449 A1ID Pharma Co., Ltd.
- Modified Sendai Virus Vaccine and Imaging Vector9 Nov 2017US 2017/0321224 A1St. Jude Children's Research Hospital
- Semi-live respiratory syncytial virus vaccine1 Dec 2016US 2016/0346378 A1Amvac AG
- Semi-live respiratory syncytial virus vaccine5 May 2016US 2016/0120974 A1Amvac AG
Most cited
By later US patents
- Process for the production of virus vaccine116US 4,659,569 AKabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo · 1987
- Reconstituting viral glycoproteins into large phospholipid vesicles62US 4,871,488 AAlbany Medical College of Union University · 1989
- Cochleate delivery vehicles33US 5,994,318 AAlbany Medical College · 1999
- Compositions and methods for eliciting immune or anti-infective responses12US 7,319,000 B1Board of Regents, The University of Texas System · 2008
- Protein- or peptide-cochleate vaccines and methods of immunizing using the same11US 5,643,574 AAlbany Medical College · 1997